MAPPS | World Obesity Federation

MAPPS

The MAPPS II surveys are now live!

Share your experiences & help improve obesity care and prevention around the world

Get involved

World Obesity Federation - SCOPE

MAPPS II is generating global and country-level evidence to strengthen obesity prevention and care across health systems.

MAPPS II is a global initiative led by the World Obesity Federation between 2025 and 2027. Building on the first MAPPS project, which identified major gaps in obesity services across health systems, MAPPS II is generating updated evidence on obesity prevention, treatment and care, with a focus on health system capacity, policy action, and inequities in care pathways.

MAPPS II

The project brings together perspectives from healthcare professionals, public health and policy stakeholders, civil society, and people with lived experience of obesity. Through global surveys, in-depth country work and national stakeholder engagement, MAPPS II aims to support stronger, more equitable and integrated responses to obesity.

Get involved

If you are interested in working with us to expand this project, please contact us here: health_systems@worldobesity.org

Deep-dive country work

In addition to global activities, MAPPS II is conducting in-depth engagement in six deep-dive countries: Brazil, China, India, Saudi Arabia, South Africa and Spain.

This work explores national obesity care, prevention and policy landscapes in greater detail. Activities include stakeholder engagement, qualitative interviews, multi-stakeholder roundtables, and work to support coalition-building and advocacy.

The deep-dive process is currently underway across all six countries. Emerging findings will help identify common challenges, national priorities and opportunities to strengthen obesity policy, prevention and care.
 

Related News

View all

News Dec 12, 25

MAPPS II multisectoral roundtable in Spain identifies key priorities for obesity prevention and care

World Obesity and SEEDO co-hosted a roundtable in Toledo to examine systemic barriers to obesity prevention & care.

Read Post

News Policy & Advocacy Dec 10, 25

Strengthening obesity policy and systems in South Africa: Highlights from the MAPPS II Roundtable

We convened more than 25 stakeholders in Cape Town to explore how South Africa to explore obesity prevention & care.

Read Post

News Projects Jun 01, 26

India’s MAPPS II Roundtable: Rethinking obesity through policy, people, and multisectoral action

In April 2026, World Obesity and partners in India hosted a MAPPS II roundtable in New Delhi, India.

Read Post

Get involved with MAPPS II

The MAPPS II surveys are now live!

MAPPS II has collected global insights through surveys for healthcare professionals, public health experts, policymakers, advocacy organisations and civil society actors, people with lived experience of obesity, and caregivers. Survey findings will inform global analysis and support country-level discussions on obesity prevention, treatment, management and policy.

To participate in the MAPPS II project, you can share your understanding and experience of your country’s obesity health care system, public health and policy landscape in relation to obesity and the broader societal and social context please consider completing one or more of the surveys below:

MAPPS II

Healthcare survey

Healthcare professionals

Available in other languages:

Click the below link for English.


The main MAPPS II healthcare professional survey has now closed.

Targeted data collection remains open in selected countries, including Kingdom of Saudi Arabia, Fiji, Tonga and Kiribati, where additional responses are being sought to strengthen representation.

TAKE OUR SURVEY

MAPPS II

Policymaker survey

Public health experts, policymakers, advocacy groups & civil society 

Available in other languages:

Click the below link for English.


Open until 31 July 2026

TAKE OUR SURVEY

MAPPS II

Lived experience survey

People with lived experience of obesity and their caregivers 

Available in other languages:

Click the below link for English.


Open until 31 July 2026

TAKE OUR SURVEY

MAPPS II - Participant Information Sheet

MAPPS II - Participant Information Sheet

Frequently Asked Questions (FAQ) for participants of the MAPPS II surveys.

Download (276.27 KB)

MAPPS II - Ethics Policy

MAPPS II Ethics Policy

Download (164.4 KB)
 
 

Stay up to date and get involved with the MAPPS II project

 

 

Between 2025 and 2027, the World Obesity Federation will be leading MAPPS II, which will provide an updated understanding of global health systems and investigate the social and commercial determinants of health and inequities in obesity care and prevention pathways. 

 

This innovative project aims to improve obesity care and prevention in health systems through improved evidence generation, coalition building, and policy engagement.

World Obesity Federation is committed to protecting your privacy, and takes its responsibilities regarding the security of members' and customers' information very seriously. Our privacy policy is included here.
 
 

 

All of our MAPPS II surveys are available in several languages. We will continue to update this list as new languages become available. 


Healthcare professionals

Policymakers, advocacy groups & civil society 

People with lived experience of obesity and their caregivers 

If you have any queries about the MAPPS II project, contact our team.


Publications

The findings from the MAPPS I project have been published in Clinical Obesity and on the Global Obesity Observatory.

Country report cards

Individual country report cards based on the MAPPS research can be found on the Global Obesity Observatory.

To find a country’s report card, see visit our Global Obesity Observatory here.

COUNTRY REPORT CARDS

Any questions?

If you have any queries about the MAPPS II project, or any other area of our work, contact our team.

Contact us
Work undertaken on the MAPPS II project is partially supported by funding from various organisations:
In 2025 - Eli Lilly, Novo Nordisk, and Boehringer Ingelheim. In 2026 - Eli Lilly, Novo Nordisk and Amgen.
These organisations have no input into or influence over the content or execution of the project, or any materials/activities that are developed as part of this project.